Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):486-487. doi: 10.1136/jnnp-2018-318465. Epub 2018 Jun 21.
No abstract available

Keywords: neuroimmunology.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • B-Lymphocytes
  • Child
  • Drug Administration Schedule
  • Female
  • Flow Cytometry
  • Humans
  • Immunologic Factors / administration & dosage*
  • Immunologic Memory
  • Maintenance Chemotherapy
  • Male
  • Middle Aged
  • Neuromyelitis Optica / drug therapy*
  • Rituximab / administration & dosage*
  • Young Adult

Substances

  • Immunologic Factors
  • Rituximab